arTIcle | PaTienT exPerience |
2.5 2
1.5 1
0.5 0
Before Immediately after
14 days 30 days safety assessments were
performed at day 0, day 14 and day 30, after the injections. Potential side‑effects that were noted included redness, bruising, swelling, itching, nodules and pain.
techniques are multiple, and the assumption is that
the experienced injector is able to select the right technique for each indication, no specific instructions with regard to technique were given. investigators applied the filler according to their usual practice using the technique of their choice. The injection volume was also selected at the discretion of the investigator to reach a full correction. The exact injection volume was documented. The range of the volume of Princess Filler injected per side in each area treated was between 0.15 ml to 0.9 ml.
90 days 135 days
180 days
240 days
Figure 1 Wrinkle severity assessment score by investigators during follow up period of 240 days (1=complete correction to fin; 2=moderate; 3=deep to severe; 4=extreme)
The investigators were allowed to perform a single
touch-up treatment after 14 or 30 days, if full correction of the wrinkle was not achieved according to the investigator’s or a patient’s opinion.
Data collection The severity of folds and wrinkling was assessed by the investigators on a four-point wrinkle assessment scale (WaS), the points of which were defined as: ■ 1 = mild wrinkle ■ 2 = moderate wrinkle ■ 3 = severe wrinkle ■ 4 = extreme wrinkle. Wrinkle assessments were carried out immediately
before and after treatment (baseline, day 0), and on days 14, 30, 90, 135, 180, and 240. Patients’ and investigators’ degrees of satisfaction were assessed using a four-point scale:
■ 1 = no effect ■ 2 = some improvement ■ 3 = reached expectations ■ 4 = overcorrection. Patients were followed for 240 days after the first
injection. The degree of satisfaction was scored at every visit: day 1, day 14 (touch-up possible), day 30 (touch-up possible), day 90, day 135, day 180 and day 240. Safety assessments were performed at day 0, day 14
and day 30 after the injections. Potential side-effects that were noted included redness, bruising, swelling, itching, nodules and pain.
Figure 2 A patient (A) before, (B) immediately after, (C) 30 days after, and (D) 240 days following the injection of 1 ml of Princess Filler in the nasolabial folds
Results Subjects a total of 71 patients were recruited and treated, with a ratio of 7% male and 93% female. The mean age was 51 years (range 25–70 years). The number of subjects
46
❚
November/December 2011 |
prime-journal.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84